Product Reports Resources Pricing Login Book a demo

DNAnexus

Biotech & Life Sciences · Mountain View, United States · Founded 2009

DNAnexus is a technology startup that operates in the biomedical sector, providing a platform for precision health data analysis. The company's primary clientele includes biomedical organizations looking to accelerate their scientific discoveries. DNAnexus offers a comprehensive solution for managing, analyzing, and collaborating on multimodal data, which is data from different sources or formats. This helps clients unlock valuable insights to improve patient care. The company operates on a business model that provides clients with a secure environment to run predictive analytics, using artificial intelligence (AI) and machine learning algorithms. This helps to accelerate insight generation and improve decision-making. DNAnexus also offers pre-built tools and apps to save time and accelerate analyses. In addition to this, the company provides support for multiple workflow languages and the ability to integrate clients' own tools. This allows for a streamlined experience for both technical and non-technical teams. DNAnexus also offers a powerful cohort browser and integrated JupyterLab notebooks for deep dataset analysis. The company's revenue model is likely based on a subscription or usage-based fee for access to its platform and tools. DNAnexus claims that its customers can experience a 395% return on investment (ROI), indicating a strong value proposition for its services. Keywords: Biomedical, Precision Health Data, Multimodal Data, AI, Machine Learning, Predictive Analytics, Workflow Languages, Cohort Analysis, Data Visualization, Bioinformatics.

Valuation $500M–1B
Revenue $10–50M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for DNAnexus and the history behind them.

Investors

18 investors on DNAnexus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage
Claremont Creek Ventures (CCV)
Foresite Capital
Midcap Financial
Genuity Science
Microsoft
Claremont Creek Ventures
Innovatus Capital Partners
Perceptive Advisors
Northpond Ventures
Blackstone

Global footprint

Where DNAnexus has talent and traffic

Workforce by country
12 countries with
team presence
🇺🇸 United States53.7%
🇨🇿 Czech Republic36%
🇻🇳 Vietnam3.7%
🇬🇧 United Kingdom1.9%
🇮🇪 Ireland0.9%
Top 5 of 12 shown
Web traffic by country
53K monthly visits
across markets
🇺🇸 United States30.2%
🇩🇰 Denmark22.8%
🇬🇧 United Kingdom7.5%
🇦🇺 Australia5.1%
🇨🇦 Canada3.8%
Top 5 markets shown

Talent graph

The shape of DNAnexus's talent

Dealroom maps DNAnexus's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

6 standout operatorsDealroom-flagged across the org
4 AI specialistsincl. 1 core researchers
276 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock DNAnexus's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about DNAnexus

An AI-synthesized read of the highest-engagement posts about DNAnexus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DNAnexus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.